IMU-381

Immunic has selected IMU-381 as a development candidate to specifically address the needs of gastrointestinal diseases.

IMU-381 is a next generation molecule with improved overall properties, supported by a series of chemical derivatives. IMU-381 is currently in preclinical testing.